{"id":"NCT00768287","sponsor":"Medexus Pharma, Inc.","briefTitle":"Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B","officialTitle":"Phase I/II/III Pharmacokinetic and Outcome Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-01","primaryCompletion":"2013-03","completion":"2016-12","firstPosted":"2008-10-08","resultsPosted":"2018-09-10","lastUpdate":"2021-04-06"},"enrollment":77,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Hemophilia B"],"interventions":[{"type":"BIOLOGICAL","name":"IB1001","otherNames":["Recombinant factor IX (rFIX)","IXINITY"]},{"type":"BIOLOGICAL","name":"nonacog alfa","otherNames":["Recombinant factor IX (rFIX)","BeneFIX"]}],"arms":[{"label":"IB1001","type":"EXPERIMENTAL"},{"label":"nonacog alfa","type":"ACTIVE_COMPARATOR"}],"summary":"Primary Objective:\n\nTo evaluate the safety (acute effects associated with infusions, and inhibitor development), pharmacokinetics (PK), and efficacy with respect to breakthrough bleeding during prophylaxis and with respect to control of hemorrhaging in both the prophylaxis and on demand groups of IB1001 in subjects with hemophilia B.\n\nKey Secondary Objectives:\n\nTo evaluate the ability of IB1001 to provide coverage against bleeding under surgical circumstances; To evaluate the long-term safety and efficacy of IB1001","primaryOutcome":{"measure":"Degree of Hemorrhage Control by Treatment Regimen","timeFrame":"Prophylaxis Group Duration of Treatment: 17.9 ± 9.6 months; On Demand Group Duration of Treatment: 15.9 ± 11.5 months","effectByArm":[{"arm":"IB1001 (On Demand)","deltaMin":53,"sd":null},{"arm":"IB1001 (Prophylaxis)","deltaMin":116,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":23,"countries":["United States","France","India","Israel","Italy","Poland","United Kingdom"]},"refs":{"pmids":["28833808","22764744"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":77},"commonTop":["Headache","Arthralgia","Pyrexia","Nasopharyngitis","Limb injury"]}}